The Swiss Business Incubation Centre (BIC) of CERN Technologies entrepreneurship program is going to Phase II. Out of nearly 20 candidates from Switzerland...
More details More detailsPARK INNOVAARE is an innovation park next to the Paul Scherrer Institute PSI and its unique complex of large research facilities. It offers technology-driven...
More details(This information is only available in German) Der PARK INNOVAARE markiert einen weiteren wichtigen Meilenstein in seiner Entwicklung: Die Finanzierung...
More detailsIn a couple of weeks, London will welcome some of the world’s most innovative women from all sectors and backgrounds. The 21st Global Women Inventors,...
More detailsUnderstanding how matter creates life requires observing living cells with atomic detail. There are many ways to do so, but one possibility has been gaining...
More detailsPARK INNIVAARE is an innovation park next to the Paul Scherrer Institute PSI. It offers academic spin-offs, innovative start-ups, SMEs and big companies,...
More detailsNovartis (Switzerland) and Alphora (Canada) joined the case study program conducted as part of the Second Annual Spring Pharmaceutical Synchrotron X-Ray...
More detailsAs of today, start-ups and spin-offs, as well as small high-tech companies, younger than two years, can apply to become the next Business Incubation Centre...
More detailsInterAx Biotech AG, a spin-off of the Paul Scherrer Institute PSI and ETH Zurich, based at PARK INNOVAARE, is building a proprietary systems biology platform...
More detailsThe second annual Spring Pharmaceutical Synchrotron X-Ray Powder Diffraction (SPS-XRPD-2) Workshop, organized together with the 16th Pharmaceutical Powder...
More detailsInterAx Biotech AG is a spin off from the ETH Zürich and Paul Scherrer Institute (PSI). The company assists GPCR drug candidate design and selection by...
More detailsThis fall, Dr. Tim Grüne from the Paul Scherrer Institute (PSI) together with Crystallise! AG published the results of their joint project, presenting...
More details